Preventing postpartum hemorrhage

Sublingual misoprostol is inferior to intramuscular oxytocin for the prevention of postpartum hemorrhage (PPH) in women undergoing uncomplicated birth at a regional hospital in Uganda, according to new trial results. The randomized non-inferiority trial showed that PPH incidence in the misoprostol arm exceeded that in the oxytocin arm by 11.2 percent.